DarioHealth Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
51.00
823.00
2,803.00
5,170.00
7,394
Cost of Goods Sold (COGS) incl. D&A
839.20
2,274.00
1,678.00
3,364.00
3,859.00
5,629
Gross Income
839.20
2,223.00
855.00
561.00
1,311.00
1,765
SG&A Expense
12,723.10
8,646.00
6,843.00
10,271.00
15,730.00
19,453
EBIT
13,562.40
10,869.00
7,698.00
10,832.00
14,419.00
17,688
Unusual Expense
293.50
1,419.00
571.00
9.00
1,168.00
1
Non Operating Income/Expense
75.80
589.00
7.00
26.00
15.00
98
Interest Expense
-
-
22.00
20.00
171.00
18
Pretax Income
13,931.80
12,877.00
7,142.00
10,887.00
15,743.00
17,803
Consolidated Net Income
13,931.80
13,156.00
7,296.00
10,887.00
15,743.00
17,803
Net Income
13,931.80
13,156.00
7,296.00
10,887.00
15,743.00
17,803
Net Income After Extraordinaries
13,931.80
13,156.00
7,296.00
10,887.00
15,743.00
17,803
Net Income Available to Common
13,931.80
16,055.00
7,296.00
11,607.00
15,998.00
18,296
EPS (Basic)
68.47
33.30
3.78
2.23
1.66
0.78
Basic Shares Outstanding
203.50
482.20
1,897.80
5,203.00
9,628.30
23,412.90
EPS (Diluted)
68.47
33.30
3.84
2.23
1.66
0.78
Diluted Shares Outstanding
203.50
482.20
1,897.80
5,203.00
9,628.30
23,412.90
EBITDA
12,723.20
10,320.00
7,363.00
10,445.00
14,224.00
17,481
Other After Tax Income (Expense)
-
279.00
154.00
-
-
-
Preferred Dividends
-
2,899.00
-
720.00
255.00
493
About DarioHealth
View Profile
